-
professor will strengthen the “Quantitative Nanoimaging of Biological Systems – Organization and Dynamics” team, which focuses on cell signalling processes and develops original techniques based on tracking
-
to design a completely new material to meet a need identified by clinicians, and to conduct its preclinical and clinical evaluation in-house, enabling a rapid and efficient process. For example, we can design
-
of hemorrhagic diseases, as well as in the role played by these determinants in various processes beyond hemostasis (cancer, sepsis, etc.). The project is in line with the Unit's theme, while allowing it to
-
the societal and health impact of research conducted at the Necker site. Strategy of the host laboratory: INSERM U1151 studies pathophysiological processes affecting numerous organs (brain, kidney, liver, lungs
-
of diet (circadian rhythms, food processing, additives, etc.), chronic diseases, and metabolic health. Strategy of the host laboratory: The CRESS, recognized for its scientific excellence, is dedicated
-
precise localization of these phenotypes, further improving our understanding of tissue organization and responses. However, several biological processes that rely on dynamic transitions in cell state
-
at deciphering fundamental principles underlying biological structures and processes by integrating experimental data with computational models to uncover insights into genome evolution, molecular mechanisms, and
-
and their scientific and teaching supervision capacity. The candidates selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO
-
capacity. The candidates selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO of Inserm. Required profile: Education Level: Phd
-
and their scientific and teaching supervision capacity. The candidates selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO